Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

IO Biotech Announces Clinical Collaboration with MSD to Evaluate IO102-IO103 with … – BioSpace,

In a Phase 1/2 clinical trial of 30 patients with metastatic melanoma, IO102-IO103, in combination with anti PD1 mAb, demonstrated an ability to …, In a Phase 1/2 clinical trial of 30 patients with metastatic melanoma, IO102-IO103, in combination with anti PD1 mAb, demonstrated an ability to …, Read More

Scroll to Top